ClinicalTrials.Veeva

Menu

Interest of Virtual Reality to Reduce Patient Anxiety During the Placement of a Percutaneous Implantable Port Catheter (RV-CIP)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

CIP
Anxiety

Treatments

Device: Virtual reality

Study type

Interventional

Funder types

Other

Identifiers

NCT05527379
69HCL19_0824

Details and patient eligibility

About

The Vascular Access Unit (UAV) of the Lyon Sud Hospital Center is the first unit within a French public establishment where the Regional Health Agency (ARS) has authorized that medical procedures for the installation of central venous access be performed by nurses.

The installation of CIP represents an anxiety-provoking step for the patient, because the gesture, which consists of inserting a box under the skin, connected to a catheter, placed in a deep vein, involves uncomfortable, even painful moments. In the UAV, the installation of this device is carried out in the operating room, without premedication and only under local anesthesia. Affected patients usually have a diagnosis of serious illness (oncology).

Virtual Reality (VR) simulates the physical presence of the patient in an environment artificially generated by software. Many applications have already been evaluated in different health sectors, the investigators would like to show its interest in reducing patient anxiety during CIP placement under local anesthesia, without premedication.

The medical device used is Lumeen. It is a Class I medical device software within the meaning of Regulation (EU) 2017/745, CE marked. In the context of research, the Relaxation module is used. This module is the one intended for the management of anxiety and pain induced by medical procedures in adults and children over 6 years of age. It allows to perform immersions in 360° videos in real shots or computer-generated images, accompanied by natural sounds, relaxing music and a relaxation script recorded by hypnotherapists. The duration of an immersion can be adjusted according to the needs of the medical procedure..

Enrollment

120 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patient ≥18 years old
  • Patient operated on an outpatient basis and available for a phone call between D+1 and D+5
  • Patient operated for a 1st pose of CIP at the UAV
  • Patient whose anxiety measured by ENS Anxiety is at least 4/10 at entry
  • Patient having signed the Informed Consent
  • Patient affiliated to a social security

Exclusion criteria

  • Patient not sufficiently fluent in the French language, in the judgment of the investigator, to allow him a good understanding of the implementation and the interest of the virtual reality headset material;
  • Patient with motion sickness;
  • Patient participating in another study who, in the judgment of the investigator, could interfere with the results of this research protocol;
  • Patient deprived of liberty or placed under guardianship or curators;
  • Pregnant or breastfeeding women;
  • Patient with a history of epilepsy ;
  • Patient with a pacemaker or pacemaker;
  • Patient with psychiatric disorders of a psychotic nature in the acute phase or visual hallucinations;
  • Patient under anxiolytic treatment;
  • Patient presenting wounds or infections on the level of the head not allowing the installation of the virtual reality helmet.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

120 participants in 1 patient group

CIP procedure under virtual reality
Experimental group
Description:
CIP procedure under virtual reality
Treatment:
Device: Virtual reality

Trial contacts and locations

1

Loading...

Central trial contact

Stéphanie VICENTE; Annie de FILIPPIS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems